Avricore Health (AVCRF) Liabilities and Shareholders Equity (2009 - 2026)

Avricore Health (AVCRF) has reported Liabilities and Shareholders Equity for 18 consecutive years, with $426125.2 the latest figure, recorded in Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity fell 71.42% year-over-year to $426125.2; the TTM figure through Jun 2026 stood at $1.8 million (down 72.64% YoY), while the FY2025 annual figure was $403040.6, down 75.99% from the prior year.
• Liabilities and Shareholders Equity climbed to $426125.2 in Q1 2026 per AVCRF's latest filing, from $403809.2 in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $2.2 million in Q3 2024 and bottomed at $403809.2 in Q4 2025.
• Historically, Liabilities and Shareholders Equity has averaged $1.5 million across 5 years, with a median of $1.6 million in 2024.
• Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity climbed 22.23% — and 2025, when it slumped 75.46%.
• Avricore Health's Liabilities and Shareholders Equity stood at $1.9 million in 2022, then retreated by 1.49% to $1.9 million in 2023, then fell by 11.75% to $1.6 million in 2024, then plunged by 75.46% to $403809.2 in 2025, then increased by 5.53% to $426125.2 in 2026.
• Business Quant data shows AVCRF's Liabilities and Shareholders Equity at $426125.2 in Q1 2026, $403809.2 in Q4 2025, and $965908.6 in Q3 2025.